Medical News

RSS

REST molecule acts as an adapter in stem cells, times neuronal development

Upon fertilisation, a single cell is formed when egg and sperm fuse. Our entire body, with more than 200 specialised cell types and billions of cells are formed from this single cell. It is a scientific mystery how the early stem cells know what cell type to become, but a precise timing of the process is crucial for correct development and function of our body.

3 Mar 2012

Abstinence therapy safer, preferable for opioid-addicted HCPs

Many health care professionals (HCPs) have easy access to controlled medications and the diversion and abuse of drugs among this group may be as high as 10%. Controversy surrounds the safety of allowing addicted HCPs to return to clinical practice while undergoing medical treatment with opioid substitution therapy such as buprenorphine.

3 Mar 2012

Emotional inhibition and alexithymia are distinct phenomena: Study

In the early 80s Robert Kellner developed the Emotional Inhibition Scale (EIS), a self-rating scale for emotional inhibition based on clinimetric principles. This study explores whether the EIS differentiated a sample of cardiac recipients from normal controls, as well as the associations between the EIS and 2 measures of alexithymia, i.e. the Toronto Alexithymia Scale-20 (TAS-20) and the Diagnostic Criteria for Psychosomatic Research.

3 Mar 2012

Older women face increased risk of late stage breast cancer diagnosis

Older women with breast cancer face a higher risk of being diagnosed with the disease at a late stage, while the risk of an advanced stage diagnosis of lung cancer decreases with age, a new study shows today.

3 Mar 2012

Scientists to develop new carbon-based biointerfaces

In the future, neural implants could replace destroyed sensory cells in the eye or ear - a dream come true for humanity. One of the greatest challenges yet to be addressed is designing the interface between medical technology and human tissue. In order to overcome the limitations of existing models, scientists from Forschungszentrum Juelich and eleven other institutions involved in the NeuroCare project, which kicked off on 1 March 2012, will develop novel biointerfaces made of carbon.

3 Mar 2012

Maintaining healthy lifestyle from young adulthood linked with low CVD risk in middle age

Maintaining a healthy lifestyle from young adulthood into your 40s is strongly associated with low cardiovascular disease risk in middle age, according to a new Northwestern Medicine study.

3 Mar 2012

Long-term data from Baxter's HyQ clinical study on PI

Baxter International Inc. today announced the presentation of additional long-term data supporting the clinical profile of HyQ, its investigational combination product for use in patients with primary immunodeficiencies.

From Baxter International Inc. 3 Mar 2012

Critical new details about structure of enterovirus 71

Researchers have discovered critical new details about the structure of a virus that causes potentially fatal brain swelling and paralysis in children, pointing toward designs for antiviral drugs to treat the disease.

3 Mar 2012

CLR01 blocks toxic aggregations of proteins in mouse model of Parkinson's

Millions of people suffer from Parkinson's disease, a disorder of the nervous system that affects movement and worsens over time. As the world's population ages, it's estimated that the number of people with the disease will rise sharply. Yet despite several effective therapies that treat Parkinson's symptoms, nothing slows its progression.

2 Mar 2012

New way to culture stem cells in 3D environment

Stem cells are the body's mechanics, repairing damaged tissues and organs. Because these cells are able to grow into any type of cell in the body, scientists believe they hold the key to groundbreaking new therapies. To help further this research, scientists from the University of Victoria have found a new way to culture cells in 3D- a significant step forward for regenerative medicine.

2 Mar 2012

EC grants marketing authorization for Baxter's VEPACEL to treat influenza A

Baxter International Inc. announced today that the European Commission (EC) has granted marketing authorization for VEPACEL in all European Union (EU) Member States, as well as Iceland, Liechtenstein and Norway.

From Baxter International Inc. 2 Mar 2012

Teenagers with healthy behaviours more likely to have higher levels of happiness

Teenagers who turn their backs on a healthy lifestyle and turn to drink, cigarettes and junk food are significantly unhappier than their healthier peers. New research also shows that 12-13 is a catalyst age when young people turn away from the healthy habits of their younger years and start to get involved in risky behaviours.

2 Mar 2012

Watson introduces generic PROMETRIUM for endometrial hyperplasia

Watson Pharmaceuticals, Inc. today confirmed that Watson has launched an authorized generic version of PROMETRIUM (progesterone, USP) Capsules 100mg and 200mg, as part of an agreement with Abbott Laboratories.

2 Mar 2012

New ACR classification criteria for polymyalgia rheumatica

The American College of Rheumatology has released the first classification criteria for polymyalgia rheumatica - aimed at helping physicians identify patients with this condition, which occurs in persons aged 50 years or older who have recent onset of pain in the shoulders, neck and hips along with other inflammatory symptoms not explained by an alternate diagnosis.

2 Mar 2012

GOP presidential candidates go on attack with charges related to contraception, health reforms and the individual mandate

Republican presidential hopefuls Rick Santorum and Ron Paul launch new criticisms of Mitt Romney and Newt Gingrich - not to mention of each other.

2 Mar 2012

Trans fats raises stroke risk in women – aspirin lowers risk

A new study finds that older women who take in substantial amount of trans fats are more likely than their counterparts to suffer an ischemic stroke. However, the risk of stroke associated with trans fat intake was lower among women taking aspirin, according to the findings from University of North Carolina at Chapel Hill researchers. The report, “Trans Fat Intake, Aspirin and Ischemic Stroke Among Postmenopausal Women,” was published today online in the journal Annals of Neurology.

2 Mar 2012

FDA takes more time to decide on the fate of BMS & Pfizer’s joint venture anticlotting drug Eliquis

The U.S FDA have pushed back the deadline for deciding whether to approve an experimental anticlotting drug developed jointly by Pfizer Inc. and Bristol-Myers Squibb Co. The companies said late Wednesday that the Food and Drug Administration has set a new target date of June 28 for deciding whether to approve Eliquis. That’s three months later than originally scheduled.

2 Mar 2012

Packaged meats to carry nutrition labels like other food products

Starting this Thursday nutrition labels found on almost all packaged foods can be found for ground meat and poultry as well. Forty of the most popular whole, raw cuts or meat and poultry, such as chicken breast or steak, also will have nutritional information either on the package labels or on display at the store, under a new Department of Agriculture rule. The department's Food Safety and Inspection Service has required nutrition labeling since 1993 for products that are not raw or that contain more than one ingredient.

2 Mar 2012

Safe sex apps anyone?

As part of National Condom Week (Feb. 14 - Feb. 21), Planned Parenthood of the Great Northwest distributed 55,000 condoms throughout western Washington. The condom packaging contained QR codes, barcodes that can be scanned by smart phones which direct users to a mobile website. The website is www.WhereDidYouWearIt.com, a geo-location service website that allows users to “check-in” their safe sex activity. The site is intended to promote healthy sexuality and encourage social media users, to “be proud to wear protection,” Planned Parenthood said in a written statement. “Wheredidyouwearit.com is like Foursquare for people who don’t want a sexually transmitted infection,” PPGNW said on its website.

2 Mar 2012

Quadrivalent flu vaccine that fights against four strains of Influenza approved

The FluMist Quadrivalent vaccine from AstraZeneca's MedImmune unit protects against two strains of influenza A and two strains of influenza B, and is approved for people ages 2 to 49. Similar to the previously approved FluMist, the new vaccine is a nasal spray that delivers weakened strains of the virus. The vaccine, FluMist Quadrivalent (MedImmune), will be available for the 2013-2014 flu season.

2 Mar 2012